Kingsview Wealth Management, LLC Novartis Ag Transaction History

Kingsview Wealth Management, LLC

  • $4.45 Billion
  • Q3 2024

A detailed history of Kingsview Wealth Management, LLC transactions in Novartis Ag stock. As of the latest transaction made, Kingsview Wealth Management, LLC holds 7,674 shares of NVS stock, worth $800,244. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,674
Previous 8,376 8.38%
Holding current value
$800,244
Previous $891,000 1.01%
% of portfolio
0.02%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $74,503 - $84,864
-702 Reduced 8.38%
7,674 $882,000
Q2 2024

Aug 14, 2024
SELL
$92.57 - $107.37 $62,021 - $71,937
-670 Reduced 7.41%
8,376 $891,000
Q1 2024

May 09, 2024
BUY
$95.27 - $108.47 $49,254 - $56,078
517 Added 6.06%
9,046 $875,000
Q4 2023

Feb 08, 2024
SELL
$92.27 - $101.54 $39,307 - $43,256
-426 Reduced 4.76%
8,529 $861,000
Q3 2023

Nov 07, 2023
BUY
$94.73 - $105.13 $74,552 - $82,737
787 Added 9.64%
8,955 $912,000
Q2 2023

Aug 10, 2023
BUY
$92.52 - $104.91 $99,644 - $112,988
1,077 Added 15.19%
8,168 $824,000
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $48,178 - $55,871
-602 Reduced 7.83%
7,091 $652,000
Q4 2022

Feb 13, 2023
BUY
$75.55 - $92.52 $13,750 - $16,838
182 Added 2.42%
7,693 $697,000
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $12,310 - $14,397
-165 Reduced 2.15%
7,511 $571,000
Q2 2022

Aug 16, 2022
SELL
$80.52 - $93.75 $5,072 - $5,906
-63 Reduced 0.81%
7,676 $649,000
Q1 2022

Feb 08, 2024
SELL
$80.11 - $90.62 $218,219 - $246,848
-2,724 Reduced 31.94%
5,805 $509,000
Q4 2021

Feb 17, 2022
SELL
$79.7 - $88.13 $26,380 - $29,171
-331 Reduced 4.1%
7,739 $677,000
Q3 2021

Dec 03, 2021
BUY
$81.78 - $95.14 $25,433 - $29,588
311 Added 4.01%
8,070 $660,000
Q2 2021

Aug 17, 2021
BUY
$85.24 - $94.15 $71,601 - $79,086
840 Added 12.14%
7,759 $711,000
Q1 2021

May 24, 2021
BUY
$83.5 - $98.47 $63,627 - $75,034
762 Added 12.38%
6,919 $596,000
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $16,550 - $20,019
-212 Reduced 3.33%
6,157 $581,000
Q3 2020

Nov 19, 2020
SELL
$82.14 - $91.0 $92,900 - $102,921
-1,131 Reduced 15.08%
6,369 $554,000
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $345,247 - $388,632
-4,266 Reduced 36.26%
7,500 $655,000
Q1 2020

May 11, 2020
BUY
$70.67 - $99.01 $354,551 - $496,733
5,017 Added 74.34%
11,766 $970,000
Q4 2019

Jan 31, 2020
BUY
$84.35 - $95.37 $47,151 - $53,311
559 Added 9.03%
6,749 $639,000
Q4 2019

Jan 30, 2020
BUY
$84.35 - $95.37 $34,583 - $39,101
410 Added 7.09%
6,190 $520,000
Q3 2019

Jan 29, 2020
BUY
$85.54 - $94.26 $26,004 - $28,655
304 Added 5.55%
5,780 $502,000
Q2 2019

Jan 29, 2020
SELL
$75.4 - $92.8 $41,696 - $51,318
-553 Reduced 9.17%
5,476 $500,000
Q1 2019

Jan 29, 2020
BUY
$75.32 - $86.15 $72,985 - $83,479
969 Added 19.15%
6,029 $580,000
Q4 2018

Jan 29, 2020
BUY
$73.66 - $82.02 $4,345 - $4,839
59 Added 1.18%
5,060 $434,000
Q3 2018

Jan 29, 2020
SELL
$66.94 - $77.43 $118,952 - $137,593
-1,777 Reduced 26.22%
5,001 $431,000
Q2 2018

Jan 29, 2020
SELL
$64.91 - $73.36 $3,245 - $3,668
-50 Reduced 0.73%
6,778 $512,000
Q1 2018

Jan 29, 2020
BUY
$70.39 - $84.15 $44,908 - $53,687
638 Added 10.31%
6,828 $552,000
Q4 2017

Jan 29, 2020
BUY
$72.33 - $77.64 $199,920 - $214,596
2,764 Added 80.68%
6,190 $520,000
Q3 2017

Jan 29, 2020
BUY
$74.14 - $77.27 $59,534 - $62,047
803 Added 30.61%
3,426 $294,000
Q2 2017

Jan 29, 2020
BUY
N/A
2,623
2,623 $219,000

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email